Medline (MDLN) Long-Term Deferred Tax (2025 - 2026)

Medline's (MDLN) quarterly Long-Term Deferred Tax came in at $837.0 million in Q1 2026, up 43.57% on a QoQ basis from $583.0 million in Q4 2025.

Medline (MDLN) Long-Term Deferred Tax (2025 - 2026) Analysis & Trends

Medline (MDLN) has 2 years of Long-Term Deferred Tax data on file, last reported at $837.0 million in Q1 2026.

On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $837.0 million in Q1 2026; TTM through Mar 2026 was $837.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $583.0 million, changed N/A from the prior year.
Long-Term Deferred Tax for Q1 2026 stood at $837.0 million, up from $583.0 million in the prior quarter.
Over the last five years, Long-Term Deferred Tax for MDLN reached as high as $837.0 million in Q1 2026 and fell as low as $583.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Baxter International	11.17 Bn	9.12 Bn	891.00 Mn

Download Data

Date	Value
Mar 28, 2026	837.00 Mn
Dec 31, 2025	583.00 Mn